Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM

被引：12
|
作者：
Devizzi, Liliana [1 ]
Guidetti, Anna [1 ]
Seregni, Ettore [1 ]
Passera, Roberto [2 ]
Maccauro, Marco [1 ]
Magni, Michele [1 ]
Testi, Adele [1 ]
Di Nicola, Massimo [1 ]
Tarella, Corrado [3 ]
Matteucci, Paola [1 ]
Viviani, Simonetta [1 ]
Ruella, Marco [3 ]
Carlo-Stella, Carmelo [4 ,5 ]
Chiesa, Carlo [1 ]
Cox, Maria Cristina [6 ]
Bombardieri, Emilio [1 ]
Gianni, Alessandro M. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Univ Turin, Turin, Italy
[3] Azienda Osped Ordine Mauriziano Umberto I, Turin, Italy
[4] Humanitas Clin & Res Ctr, Rozzano, Italy
[5] Univ Milan, Milan, Italy
[6] Univ Roma La Sapienza, Azienda Osped StAndrea, I-00185 Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 23期
关键词：
Y-90 IBRITUMOMAB TIUXETAN; FOLLOW-UP; LOW-GRADE; PHASE-II; RADIOIMMUNOTHERAPY; CHEMOTHERAPY; SAFETY; TRIAL; EFFICACY; ZEVALIN;
D O I：
10.1200/JCO.2013.50.2922
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2974 / 2976
页数：4
相关论文
共 50 条
  • [21] Combining yttrium 90-labeled ibritumomab tiuxetan with high-dose chemotherapy and stem cell support in patients with relapsed non-Hodgkin's lymphoma
    Winter, JN
    [J]. CLINICAL LYMPHOMA, 2004, 5 : S22 - S26
  • [22] High-dose radioimmunotherapy with yttrium 90 (90Y) ibritumomab tiuxetan with high-dose etoposide (VP-16) and cyclophosphamide (CY) followed by autologous hematopoietic cell transplant (AHCT) for poor-risk or relapsed B-cell non-Hodgkin's lymphoma (NHL):: Update of a phase I/II trial.
    Nademanee, A
    Forman, SJ
    Molina, A
    Kogut, N
    Fung, HC
    Yamauchi, D
    Anderson, AL
    Smith, D
    Liu, AN
    Raubitschek, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 559S - 559S
  • [23] Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma
    Krishnan, Amrita
    Nademanee, Auayporn
    Fung, Henry C.
    Raubitschek, Andrew A.
    Molina, Arturo
    Yamauchi, Dave
    Rodriguez, Roberto
    Spielberger, Ricardo T.
    Falk, Peter
    Palmer, Joycelynne M.
    Forman, Stephen J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) : 90 - 95
  • [24] Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
    Horwitz, SM
    Negrin, RS
    Blume, KG
    Breslin, S
    Stuart, MJ
    Stockerl-Goldstein, KE
    Johnston, LJ
    Wong, RM
    Shizuru, JA
    Horning, SJ
    [J]. BLOOD, 2004, 103 (03) : 777 - 783
  • [25] High-Dose Therapy/Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Marginal Zone Non-Hodgkin Lymphoma
    Li, Lanfang
    Bierman, Philip
    Vose, Julie
    Loberiza, Fausto
    Armitage, James O.
    Bociek, R. Gregory
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (03): : 253 - 256
  • [26] Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®)
    C. Chiesa
    F. Botta
    A. Coliva
    M. Maccauro
    L. Devizzi
    A. Guidetti
    C. Carlo-Stella
    E. Seregni
    M. A. Gianni
    E. Bombardieri
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1745 - 1757
  • [27] Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (ZevalinA®)
    Chiesa, C.
    Botta, F.
    Coliva, A.
    Maccauro, M.
    Devizzi, L.
    Guidetti, A.
    Carlo-Stella, C.
    Seregni, E.
    Gianni, M. A.
    Bombardieri, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (11) : 1745 - 1757
  • [28] High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis
    Gopal, AK
    Gooley, TA
    Maloney, DG
    Petersdorf, SH
    Eary, JF
    Rajendran, JG
    Bush, SA
    Durack, LD
    Golden, J
    Martin, PJ
    Matthews, DC
    Appelbaum, FR
    Bernstein, ID
    Press, OW
    [J]. BLOOD, 2003, 102 (07) : 2351 - 2357
  • [29] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE AND AUTOLOGOUS STEM-CELL RESCUE IN THE TREATMENT OF NON-HODGKIN LYMPHOMA
    SIEGERT, W
    [J]. PATHOLOGIE BIOLOGIE, 1993, 41 (01): : 104 - 104
  • [30] High-dose chemotherapy with autologous stem cell transplantation in poor-risk aggressive non-Hodgkin lymphoma in first complete remission: an analysis of the prospective Tunisian study
    Torjemane, L.
    Ladeb, S.
    Lakhal, A.
    Abdelkefi, A.
    Ben Abdelhadhim, A.
    Ben Othman, T.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S256 - S256
12345